misonidazole has been researched along with Leukemia L 1210 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mulcahy, RT; Siemann, DW | 1 |
Erickson, LC; McManus, ME; Ramonas, LM | 1 |
Scavone, SV; Sebolt-Leopold, JS | 1 |
Adomat, H; Chaplin, DJ; Farrell, NP; Skov, KA | 1 |
4 other study(ies) available for misonidazole and Leukemia L 1210
Article | Year |
---|---|
In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Topics: Animals; Carmustine; Cell Line; Drug Resistance; Drug Synergism; Humans; Leukemia L1210; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Sarcoma, Experimental | 1983 |
The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
Topics: Anaerobiosis; Animals; Antineoplastic Agents; Cells, Cultured; Cross-Linking Reagents; Cyclophosphamide; DNA, Neoplasm; Drug Interactions; Leukemia L1210; Mice; Misonidazole; Nitroimidazoles; Oxygen | 1982 |
Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor.
Topics: Alkylating Agents; Animals; Carmustine; Drug Synergism; In Vitro Techniques; Isoquinolines; Leukemia L1210; Misonidazole; Poly(ADP-ribose) Polymerase Inhibitors; Streptozocin; Tumor Cells, Cultured | 1992 |
Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
Topics: Aerobiosis; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cisplatin; DNA; DNA Restriction Enzymes; Drug Design; Drug Resistance; Leukemia L1210; Metronidazole; Misonidazole; Oxidation-Reduction; Tumor Cells, Cultured | 1990 |